Haoxi Health Technology Limited Research and Development Expense
Haoxi Health Technology Limited (HAO) reported Research and Development Expense of $79.54 thousand for the 12-month period ending 2025-06-30, per its 20-F filed 2025-10-20.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:ResearchAndDevelopmentExpense · last filed 2025-10-20
| Period end | Research and Development Expense 6 month | Research and Development Expense 12 month |
|---|---|---|
| 2025-06-30 | $79.54K 20-F · filed 2025-10-20 | |
| 2024-12-31 | $67.56K 6-K · filed 2025-04-23 | |
| 2024-06-30 | $79.98K 20-F · filed 2025-10-20 | |
| 2023-12-31 | $30.84K 6-K · filed 2025-04-23 | |
| 2023-06-30 | $58.16K 20-F · filed 2025-10-20 | |
| 2022-06-30 | $102.52K 20-F · filed 2024-10-29 |